NEXVIAZYME
Active Ingredient: AVALGLUCOSIDASE ALFA
Product Overview
About NEXVIAZYME
NEXVIAZYME is a prescription medication containing the active ingredient AVALGLUCOSIDASE ALFA, a recombinant human lysosomal acid alpha-glucosidase enzyme. It is used to treat Pompe disease, a rare genetic disorder caused by the deficiency of this enzyme.
Key Benefits & Uses
- Treatment of Pompe disease in patients with a confirmed deficiency of acid alpha-glucosidase (GAA) enzyme.
- Reduction of glycogen accumulation in muscle cells, thereby alleviating symptoms of the disease.
- Improvement in muscle strength and function in patients with Pompe disease.
Active Ingredient & Action
AVALGLUCOSIDASE ALFA, the active ingredient in NEXVIAZYME, works by replacing the deficient enzyme in patients with Pompe disease. It breaks down glycogen into glucose, which is then utilized by the body for energy. This helps to reduce glycogen accumulation in muscle cells and alleviate symptoms of the disease.
Important Notes
NEXVIAZYME is available in a lyophilized powder form for reconstitution with sterile water. It should be administered intravenously every 2 weeks. Patients should be closely monitored for signs of infusion reactions, muscle weakness, and other potential side effects. It is essential to follow the recommended dosing schedule and consult a healthcare professional for proper guidance.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.